Cargando…

Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies

OBJECTIVE: To report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma. METHODS: A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using...

Descripción completa

Detalles Bibliográficos
Autores principales: Guasp, Mar, Landa, Jon, Martinez-Hernandez, Eugenia, Sabater, Lidia, Iizuka, Takahiro, Simabukuro, Mateus, Nakamura, Masataka, Kinoshita, Makoto, Kurihara, Masanori, Kaida, Kenichi, Bruna, Jordi, Kapetanovic, Solange, Sánchez, Pedro, Ruiz-García, Raquel, Naranjo, Laura, Planagumà, Jesús, Muñoz-Lopetegi, Amaia, Bataller, Luis, Saiz, Albert, Dalmau, Josep, Graus, Francesc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312280/
https://www.ncbi.nlm.nih.gov/pubmed/34301822
http://dx.doi.org/10.1212/NXI.0000000000001053
_version_ 1783729117207724032
author Guasp, Mar
Landa, Jon
Martinez-Hernandez, Eugenia
Sabater, Lidia
Iizuka, Takahiro
Simabukuro, Mateus
Nakamura, Masataka
Kinoshita, Makoto
Kurihara, Masanori
Kaida, Kenichi
Bruna, Jordi
Kapetanovic, Solange
Sánchez, Pedro
Ruiz-García, Raquel
Naranjo, Laura
Planagumà, Jesús
Muñoz-Lopetegi, Amaia
Bataller, Luis
Saiz, Albert
Dalmau, Josep
Graus, Francesc
author_facet Guasp, Mar
Landa, Jon
Martinez-Hernandez, Eugenia
Sabater, Lidia
Iizuka, Takahiro
Simabukuro, Mateus
Nakamura, Masataka
Kinoshita, Makoto
Kurihara, Masanori
Kaida, Kenichi
Bruna, Jordi
Kapetanovic, Solange
Sánchez, Pedro
Ruiz-García, Raquel
Naranjo, Laura
Planagumà, Jesús
Muñoz-Lopetegi, Amaia
Bataller, Luis
Saiz, Albert
Dalmau, Josep
Graus, Francesc
author_sort Guasp, Mar
collection PubMed
description OBJECTIVE: To report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma. METHODS: A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using reported techniques. RESULTS: Patients' median age was 52 years (range: 23–88 years). Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABA(A)R) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). Concurrent antibodies against intracellular antigens occurred in 13 (30%; 9 anti–collapsin response mediator protein 5 [CRMP5]) and were more frequent in anti-AMPAR encephalitis (54% vs 20%; p = 0.037). The most common clinical presentation was encephalitis with multiple T2/fluid-attenuated inversion recovery hyperintense lesions in 23 (53%) patients (15 GABA(A)R, 5 AMPAR, and 1 unknown neuropil antibody), followed by encephalitis with peripheral nerve hyperexcitability in 7 (16%; 4 CASPR2, 2 LGI1, and 1 unknown antibody), limbic encephalitis in 6 (14%; 4 AMPAR, 1 LGI1, and 1 antibody negative), progressive encephalomyelitis with rigidity and myoclonus in 4 (9%; 3 GlyR and 1 AMPAR antibodies), and encephalitis with normal MRI in 3 (7%; AMPAR antibodies). Anti-GABA(A)R encephalitis was more prevalent in Japanese patients compared with Caucasians and other ethnicities (61% vs 16%; p = 0.003). In anti-AMPAR encephalitis, 3/4 patients with poor and 0/6 with good outcome had concurrent CRMP5 antibodies (p = 0.033). Immunoprecipitation studies identified metabotropic glutamate receptor 3 antibodies that were additionally found in 5 patients (3 with and 2 without encephalitis). CONCLUSIONS: AE in patients with thymoma include several clinical-radiologic syndromes that vary according to the associated antibodies. Anti-GABA(A)R encephalitis was the most frequent AE and occurred more frequently in Japanese patients.
format Online
Article
Text
id pubmed-8312280
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-83122802021-07-26 Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies Guasp, Mar Landa, Jon Martinez-Hernandez, Eugenia Sabater, Lidia Iizuka, Takahiro Simabukuro, Mateus Nakamura, Masataka Kinoshita, Makoto Kurihara, Masanori Kaida, Kenichi Bruna, Jordi Kapetanovic, Solange Sánchez, Pedro Ruiz-García, Raquel Naranjo, Laura Planagumà, Jesús Muñoz-Lopetegi, Amaia Bataller, Luis Saiz, Albert Dalmau, Josep Graus, Francesc Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: To report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma. METHODS: A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using reported techniques. RESULTS: Patients' median age was 52 years (range: 23–88 years). Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABA(A)R) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). Concurrent antibodies against intracellular antigens occurred in 13 (30%; 9 anti–collapsin response mediator protein 5 [CRMP5]) and were more frequent in anti-AMPAR encephalitis (54% vs 20%; p = 0.037). The most common clinical presentation was encephalitis with multiple T2/fluid-attenuated inversion recovery hyperintense lesions in 23 (53%) patients (15 GABA(A)R, 5 AMPAR, and 1 unknown neuropil antibody), followed by encephalitis with peripheral nerve hyperexcitability in 7 (16%; 4 CASPR2, 2 LGI1, and 1 unknown antibody), limbic encephalitis in 6 (14%; 4 AMPAR, 1 LGI1, and 1 antibody negative), progressive encephalomyelitis with rigidity and myoclonus in 4 (9%; 3 GlyR and 1 AMPAR antibodies), and encephalitis with normal MRI in 3 (7%; AMPAR antibodies). Anti-GABA(A)R encephalitis was more prevalent in Japanese patients compared with Caucasians and other ethnicities (61% vs 16%; p = 0.003). In anti-AMPAR encephalitis, 3/4 patients with poor and 0/6 with good outcome had concurrent CRMP5 antibodies (p = 0.033). Immunoprecipitation studies identified metabotropic glutamate receptor 3 antibodies that were additionally found in 5 patients (3 with and 2 without encephalitis). CONCLUSIONS: AE in patients with thymoma include several clinical-radiologic syndromes that vary according to the associated antibodies. Anti-GABA(A)R encephalitis was the most frequent AE and occurred more frequently in Japanese patients. Lippincott Williams & Wilkins 2021-07-23 /pmc/articles/PMC8312280/ /pubmed/34301822 http://dx.doi.org/10.1212/NXI.0000000000001053 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Guasp, Mar
Landa, Jon
Martinez-Hernandez, Eugenia
Sabater, Lidia
Iizuka, Takahiro
Simabukuro, Mateus
Nakamura, Masataka
Kinoshita, Makoto
Kurihara, Masanori
Kaida, Kenichi
Bruna, Jordi
Kapetanovic, Solange
Sánchez, Pedro
Ruiz-García, Raquel
Naranjo, Laura
Planagumà, Jesús
Muñoz-Lopetegi, Amaia
Bataller, Luis
Saiz, Albert
Dalmau, Josep
Graus, Francesc
Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
title Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
title_full Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
title_fullStr Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
title_full_unstemmed Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
title_short Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
title_sort thymoma and autoimmune encephalitis: clinical manifestations and antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312280/
https://www.ncbi.nlm.nih.gov/pubmed/34301822
http://dx.doi.org/10.1212/NXI.0000000000001053
work_keys_str_mv AT guaspmar thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT landajon thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT martinezhernandezeugenia thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT sabaterlidia thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT iizukatakahiro thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT simabukuromateus thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT nakamuramasataka thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT kinoshitamakoto thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT kuriharamasanori thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT kaidakenichi thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT brunajordi thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT kapetanovicsolange thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT sanchezpedro thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT ruizgarciaraquel thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT naranjolaura thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT planagumajesus thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT munozlopetegiamaia thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT batallerluis thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT saizalbert thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT dalmaujosep thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies
AT grausfrancesc thymomaandautoimmuneencephalitisclinicalmanifestationsandantibodies